Breaks Categories: News

WednesdayNov 06, 2019 9:59 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) to Release Q3 2019 Financial Results on November 14

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, on Tuesday announced that it will be releasing its third quarter 2019 earnings after market close on Thursday, November 14, 2019. The company will be holding a conference call led by CEO Brian Athaide and CFO Sean Bovingdon to discuss the results and future outlook on November 15, 2019 at 9:00 AM ET. Interested parties may join the call by dialing the Toronto line (+1) 416 764-8688 or the North America line (+1) 888 390-0546 using conference ID 46182744. A replay of the…

Continue Reading

TuesdayNov 05, 2019 1:11 pm

CannabisNewsBreaks – WeedMD Inc. (TSX.V: WMD) (OTCQX: WDDMF) (FSE: 4WE) Posts Corporate Update, Schedules Q3 Earnings Conference Call

WeedMD (TSX.V: WMD) (OTCQX: WDDMF) (FSE: 4WE), a federally licensed producer and distributor of medical-grade cannabis, this morning issued an operational update. Per the update, the company has successfully completed the harvest of its 27-acre crop of outdoor cannabis at its Strathroy facility. WeedMD intends to provide metrics, including total yield of the harvest, in conjunction with its upcoming earnings announcement. The company also detailed its entrance into commercial extraction operations at its Aylmer facility, where it has obtained a Health Canada license to produce and sell cannabis concentrates, edibles and topicals. Among other highlights, the press release also included…

Continue Reading

TuesdayNov 05, 2019 9:47 am

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Begin Trading on the OTCQB® Venture Market

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) today announced that it has been approved to commence trading on the OTCQB® Venture Market (the "OTCQB"), under the symbol "CANSF," beginning today, November 5, 2019. The listing will enable Willow Biosciences access to a broader base of U.S. and international retail and institutional investors, ultimately providing increased data access, transparency and liquidity to investors. "Listing on the OTCQB will allow for greater engagement with our U.S. investor base,” Willow CEO Trevor Peters said in the news release. “As we move towards scale up of ultra-pure, pharmaceutical grade cannabidiol (“CBD”) with our partner…

Continue Reading

TuesdayNov 05, 2019 9:22 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Names New Senior Advisor

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, this morning announced the appointment of Gregg Smith as a Senior Advisor for the company. Smith is the founder of Evolution VC Partners (www.EvolutionVCP.com), a New York-based “culture tech” venture investment firm with over 90 portfolio companies. Through his LLC, Smith is acquiring an equity position in LXRP by participating in the company's recently announced private placement financing of $0.45 units. “I am passionate about creating a smokeless future and recognize that the consumption methods of nicotine and cannabis will change. Lexaria's technology, DehydraTECH(TM), will completely disrupt and…

Continue Reading

MondayNov 04, 2019 1:27 pm

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Appoints Senior Vice President of Commercial, Strengthens Sales Strategy

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that Joel Toguri has joined the company as its senior vice president ("SVP") of Commercial. According to the update, Toguri’s responsibilities in this role will include establishment and oversight of the company's provincial and retail sales strategy across all brands. "Mr. Toguri's impressive career spans the cannabis, beverage alcohol and apparel industries. He brings over 20 years of regulated industry knowledge and pertinent cannabis distribution expertise to Supreme Cannabis.  It is a privilege to welcome a proven and skilled leader to our continuously improving team," Supreme Cannabis CEO Navdeep…

Continue Reading

MondayNov 04, 2019 10:34 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Bolsters Digital Sales & Marketing Expertise with Board Appointment of E-Commerce Senior Executive Jill Braff

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the U.S., today announced the addition of Brit + Co President Jill Braff to its board of directors. According to the update, Braff brings decades of experience in marketing and e-commerce through serving in various leadership roles for a number of well-known companies, including HSN, Ellen (DeGeneres) Digital Ventures, Ancestry.com, and, most recently, Brit + Co. Braff has received numerous awards and recognitions throughout her career, including being named one of the 40 Most Influential People Under 40 by Silicon Valley Business Journal and one of…

Continue Reading

WednesdayOct 30, 2019 9:33 am

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Departure of Chief Advocacy Officer

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Tuesday announced that it has parted ways with its Chief Advocacy Officer John Fowler. In the update, Supreme Cannabis thanked Fowler for his years of dedication and strong contribution to the company, as well as his passion for the cannabis plant. Fowler is a strong believer in the cultivation of high-end cannabis and was one of the original founders of Supreme Cannabis' flagship brand, 7ACRES. “We all wish John the best in his next endeavor and thank him for his commitment to the company for the last four years. John…

Continue Reading

TuesdayOct 29, 2019 10:00 am

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Enters Technology and Research Partnership with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF)

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, has entered into a technology and multi-phase research agreement with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF) ("CB2"), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community. Under the agreement, CB2 will assist in the development of VIVO's global medical product development strategy. CB2 will integrate its Clinical Data Management Software (“CDMS”) and Electronic Data Capture (“EDC”) tools to establish a better understanding of VIVO's current medical patient registry, and the companies will collaborate…

Continue Reading

ThursdayOct 24, 2019 10:38 am

CannabisNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Radicle Medical Marijuana Awarded Health Canada Oil License

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that its portfolio company, Radicle Medical Marijuana Inc., has received approval for oil sales from Health Canada. The additional license allows for the development and sale of new cannabis products, including oil and concentrates, which will open the door for Radicle's medical patients to access other product forms in the company's craft cannabis selection. “Consumer behaviors are evolving, and we believe many of today's cannabis consumers are open to trying alternatives to dried flower products,” Canopy Rivers President and CEO Narbé Alexandrian said in…

Continue Reading

ThursdayOct 24, 2019 10:05 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Applauds FDA Forward-Looking Decision on Reduced Risk Tobacco Format

Global innovator in drug delivery platforms Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced that the Food and Drug Administration ("FDA"), for the first time ever, has authorized the marketing of oral nicotine products through the Modified Risk Tobacco Product pathway. According to the update, this pathway includes product categories that could benefit from Lexaria's technology. The FDA-authorized product format is in the tobacco pouch category, similar to a mini tea-bag that is held in the mouth from which the nicotine within is absorbed. Unlike chewing tobacco, there is no need to spit. Significantly, because there is no combustion, heating…

Continue Reading